Ranbaxy Launches Generic Clarithromycin After Defeating Abbott In U.K. Court

Law360, New York (December 1, 2004, 12:00 AM EST) -- Indian drug maker Ranbaxy Laboratories Ltd. has a launched a generic version of the anti-infective drug clarithromycin in the U.K. after winning a patent infringement lawsuit brought by U.S.-based Abbott Laboratories.

Abbott had taken the Indian generic maker to court seeking to prevent Ranbaxy from launching the drug, but the High Court sided with Ranbaxy.

“In making its ruling in favor of Ranbaxy's arguments that the asserted patent was invalid on various grounds, the court agreed that the specific patent claims asserted by Abbott were invalid...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.